General Western Blot Reagents
Abcam Recombinant Hepatitis B virus Protein X (His tag), 100UG
Recombinant Hepatitis B virus Protein X (His tag) is a Hepatitis B virus adr4 Fragment protein, in the 2 to 154 aa range, expressed in Escherichia coli, with >90% purity and < 1 EU/µg endotoxin level.
Protein/ Peptide/ Enzyme Synonyms: Protein X, HBx, Peptide X, pX, X
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Agomelatine, MT1/MT2 agonist and 5-HT2C antagonist, 500MG
MW 243.3 Da, Purity >99%. Potent MT1/MT2 agonist (Ki values are 0.1 and 0.12 nM, respectively). 5-HT2C antagonist (IC50 = 270 nM). Shows antidepressant effects *in vivo*. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam trans-Zeatin, Plant growth hormone, 50MG
MW 219.24 Da, Purity >98%. Endogenous plant growth hormone. Cytokinin. Potent AHK3 ligand (Ki = 1.3 nM). Senescence-delaying hormone. Acts as a positional cue regulating lateral root spacing. Mediates plant growth and development in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ponasterone A, Ecdysone analog, 25MG
MW 464.6 Da, Purity >95%. Ecdysone (ab142425) analog. Potent ecdysteroid activity inducer (EC₅₀ = 70 nM). Increases β-galactosidase expression levels similar to Muristerone A (ab144309). Induces ecdysone-inducible mammalian expression system in vivo..
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-Nitrosodibenzylamine (NDBzA), Micronucleus-inducing mitogenic agent, 50MG
MW 226.27 Da. Micronucleus-inducing mitogenic agent. Mutagenic to Salmonella typhimurium. Genotoxic to rat hepatocytes. Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Methyl 3-hydro x yoctanoate, 3-Hydro x yoctanoic acid derivative, 25MG
MW 174.24 Da, Purity >98%. 3-Hydroxyoctanoic acid (ab144042) derivative. Polyester. Medium-chain-length 3-hydroxyalkanoate.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Sulprostone, EP1/ EP3 receptor agonist, 1MG
MW 465.65 g/mol, Purity >98%. Selective EP₁/ EP₃ receptor agonist (Ki values are 21 and 0.6 nM, respectively). PGE₂ analog.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Voriconazole (UK-109, 496), anti-fungal agent, 50MG
MW 349.31 Da, Purity >99%. Potent and broad-spectrum anti-fungal agent. Inhibits CYP450-dependent 14-α sterol demethylase, to interfere with ergosterol biosynthesis and inhibit fungal growth. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cibacron Blue 3G-A, Anthraquinone derivative dye, 1G
MW 774.2 Da. Anthraquinone derivative dye. Potent nucleotide-mimetic ligand. Ortho-isomer of Reactive Blue 2. Inhibits Na+/K+-ATPase. Antagonizes P2 receptors (IC₅₀ values are 17.4 and 9.1 μM for P2Y and P2X, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Piceatannol, Syk tyrosine kinase inhibitor, 50MG
MW 244.25 g/mol, Purity >99%. Syk tyrosine kinase inhibitor (Ki = 15 μM at Syk). Shows multiple biological activities such as anti-inflammatory, antiproliferative and immunomodulatory effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam KN-62, CaM kinase II inhibitor. P2 x 7 antagonist., 1MG
MW 721.8 Da, Purity >98%. Cell-permeable, reversible and selective inhibitor of CaM kinase II (IC50 = 500 nM). Interacts with the calmodulin binding site of the enzyme. At higher concentrations reported to inhibit GSK3β, PRAK and MAPKAP-K2. Also potent non-competitive antagonist at the P2X7 receptor (IC50 = 15 nM).
The product is subject to the following: Abcam Restricted Use Statement
Abcam NBQ x , AMPA / kainate antagonist, 50MG
MW 336.28 Da, Purity >99%. Potent, selective and competitive AMPA/kainate receptor antagonist. Neuroprotective and anticonvulsant in vivo. Water-soluble form available - please see NBQX disodium salt (ab120046).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Yohimbine hydrochloride, alpha2 adrenoceptor antagonist, 1G
MW 390.9 Da, Purity >98%. Selective α2 adrenoceptor antagonist (pKi values are 8.52, 8.00 and 9.17 for human α2A, α2B and α2C receptors, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Sumatriptan succinate, 5-HT1 receptor agonist, 50MG
MW 413.49 g/mol, Purity >99%. 5-HT₁ receptor agonist (Ki values are 17, 27 and 100 nM at 5-HT₁D, 5-HT₁B and 5-HT₁A receptors, respectively). Also shows affinity for 5-HT₁F receptor (EC₅₀ = 247 nM). Reduces vascular inflammation associated with migraine.
The product is subject to the following: Abcam Restricted Use Statement